drugset / Trial / NCT01889875

Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen

NCT01889875

RandomizedParallel-groupSingle-blindBasic science

Summary

Treatment of pollen allergies can be roughly divided into symptomatic treatment (e.g. antihistamines, steroids) and potentially curative immunotherapy. Immunotherapy can be delivered using subcutaneous or oral (mucosal) routes, with similar clinical outcome. The study seeks to compare immunological changes during subcutaneous (SCIT) and sublingual tablet (AIT) immunotherapy of grass pollen allergy (hayfever).

Timeline

Start
2010-11
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator AluTard Unknown 225 unknown
Comparator Grazax Other / unclassified 75000 unknown Other